Vaccine News and Research

Latest Vaccine News and Research

Bivalent mRNA booster vaccines provide greater short-term protection against symptomatic COVID-19 infection

One of the first real-world data studies comparing the new bivalent mRNA COVID-19 booster vaccines with the original monovalent vaccines reports the bivalent conveyed greater short-term protection against symptomatic COVID-19 infection in adults.

19 Dec 2022

Understanding why young cancer survivors often opt out of HPV vaccination

Study uncovers certain vaccine-related concerns that should be addressed by health care providers.

19 Dec 2022

Immune-evading Mycobacterium tuberculosis prevents inflammatory responses by hijacking the host’s ubiquitin

A new study discussed the findings of Chai et al., which revealed that triple specificity protein phosphatase (ptpB) secreted by Mycobacterium tuberculosis inhibits pyroptosis and the release of cytokines by macrophages, allowing M. tuberculosis to invade the immune system.

19 Dec 2022

Single-dose smallpox vaccine could be effective against mpox

Researchers estimated the efficacy of a single-dose Modified Vaccinia Ankara-Bavaria Nordic (MVA-BN) vaccine against mpox (MPX) in gay, bisexual, and other men who have sex with men (GBMSM).

19 Dec 2022

Milk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infection

Researchers longitudinally evaluated the antibody response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in lactating individuals.

19 Dec 2022

Seasonal influenza activity remains high but appears to be declining in some areas of the US

The weekly FluView Report mentions that the number of influenza cases seems to be declining in some areas in the United States. However, the overall seasonal influenza activity remains high.

19 Dec 2022

The impact of multimorbidity, smoking status, and demographics on vaccine hesitancy among pregnant women in Wales

A recent study examined the impact of multimorbidity and smoking on COVID-19 vaccine hesitancy among pregnant individuals.

19 Dec 2022

Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2

Researchers demonstrated that a trivalent vaccine against SARS-CoV-2 improved the breadth of humoral immune responses in mice.

19 Dec 2022

Rise and waning of SARS-CoV-2 antibody responses induced by mRNA vaccine booster in a healthcare worker population

Researchers reported the waning of antibodies against SARS-CoV-2 in the six months following a booster dose of the mRNA COVID-19 vaccine.

19 Dec 2022

Safety and immunogenicity of the Omicron BA.4/BA.5-containing bivalent booster mRNA-1273.222

Researchers evaluated the immunogenicity and safety of the COVID-19 bivalent mRNA vaccine mRNA-1273.222 and tested the neutralizing ability of the two bivalent vaccines — mRNA-1273.222 and mRNA-1273.214 — against the newly emergent Omicron subvariants.

19 Dec 2022

Study examines Mpox prevention with modified vaccinia Ankara (MVA)

A new Eurosurveillance study investigated the efficacy of the MVA-BN vaccine, which was administered to individuals after exposure to the virus.

18 Dec 2022

An assessment of T cell and antibody immunity against SARS-CoV-2 VOCs and the effect of booster shots

A new study in the journal Vaccines aimed to analyze the long-term kinetics of SARS-CoV-2 specific T cell and humoral responses following primary and booster vaccinations in previously infected individuals.

18 Dec 2022

Genome assembly tool could spur the development of new treatments for tuberculosis

Researchers have developed a novel genome assembly tool that could spur the development of new treatments for tuberculosis and other bacterial infections.

16 Dec 2022

Mucosal DNA vaccine provides protection against lethal SARS-CoV-2 in mice

Less known to the general public, mucosal vaccination via the mucus membranes could provide robust protection against SARS-CoV-2 infections.

16 Dec 2022

Trial results confirm the safety of three different Ebola vaccine regimens

Ebola epidemics occur periodically in various sub-Saharan African countries. While vaccines exist and have already received WHO Prequalification against the Zaire ebolavirus species, it is essential to pursue and intensify efforts to supplement the available data to develop a safe and effective Ebola vaccine strategies in adults and children alike.

16 Dec 2022

People of all age groups benefit more from COVID-19 vaccines than natural immunity, real-world study finds

In one of the first large, real-world studies comparing the effectiveness of COVID-19 vaccines versus natural immunity in protecting against death, hospitalizations and emergency department (ED) visits for any cause, including COVID, research-scientists from Regenstrief Institute, Indiana University School of Medicine and Vanderbilt University Medical Center report that people of all age groups benefited significantly more from vaccination than natural immunity acquired from a previous COVID infection.

16 Dec 2022

Researchers report the development of robust candidate single immunization PNP hydrogel COVID vaccines

Researchers developed a one-dose subunit vaccine for the induction of durable, potent, and broad immunity against SARS-CoV-2.

16 Dec 2022

Natural substances show great therapeutic potential to inhibit influenza viruses

Fever, cough, sore throat, and general malaise - the cold season is here, and not only corona but also influenza viruses are spreading again at a rapid pace.

16 Dec 2022

Study finds anti-S binding antibody levels are a valid correlate of protection against Omicron BA.1/BA.2 infections

Researchers used serological measurements from a longitudinal cohort to evaluate the use of binding antibodies against the SARS-CoV-2 spike protein receptor binding domain as correlates of protection against the immune evasive Omicron subvariants BA.1 and BA.2.

16 Dec 2022

The impact of the US vaccination program on reducing infections, hospitalizations, and deaths

A recent study reported that in the two years following the initiation of the US COVID-19 vaccination campaign, over 18 million hospitalizations and three million deaths have been prevented, and close to $1.15 trillion have been saved in medical costs.

16 Dec 2022

Vaccine News and Research

Latest Vaccine News and Research

Bivalent mRNA booster vaccines provide greater short-term protection against symptomatic COVID-19 infection

Understanding why young cancer survivors often opt out of HPV vaccination

Immune-evading Mycobacterium tuberculosis prevents inflammatory responses by hijacking the host’s ubiquitin

Single-dose smallpox vaccine could be effective against mpox

Milk antibodies against SARS-CoV-2 after booster vaccination and breakthrough infection

Seasonal influenza activity remains high but appears to be declining in some areas of the US

The impact of multimorbidity, smoking status, and demographics on vaccine hesitancy among pregnant women in Wales

Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2

Rise and waning of SARS-CoV-2 antibody responses induced by mRNA vaccine booster in a healthcare worker population

Safety and immunogenicity of the Omicron BA.4/BA.5-containing bivalent booster mRNA-1273.222

Study examines Mpox prevention with modified vaccinia Ankara (MVA)

An assessment of T cell and antibody immunity against SARS-CoV-2 VOCs and the effect of booster shots

Genome assembly tool could spur the development of new treatments for tuberculosis

Mucosal DNA vaccine provides protection against lethal SARS-CoV-2 in mice

Trial results confirm the safety of three different Ebola vaccine regimens

People of all age groups benefit more from COVID-19 vaccines than natural immunity, real-world study finds

Researchers report the development of robust candidate single immunization PNP hydrogel COVID vaccines

Natural substances show great therapeutic potential to inhibit influenza viruses

Study finds anti-S binding antibody levels are a valid correlate of protection against Omicron BA.1/BA.2 infections

The impact of the US vaccination program on reducing infections, hospitalizations, and deaths

eBook: Advancing infectious disease vaccine development eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Vaccine News and Research

Latest Vaccine News and Research

eBook: Advancing infectious disease vaccine development eBook

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Newsletters you may be interested in